235 related articles for article (PubMed ID: 8200356)
1. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis.
Zschoche A; Fürst W; Schwarzmann G; Sanhoff K
Eur J Biochem; 1994 May; 222(1):83-90. PubMed ID: 8200356
[TBL] [Abstract][Full Text] [Related]
2. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
[TBL] [Abstract][Full Text] [Related]
3. Glycosphingolipid specificity of the human sulfatide activator protein.
Vogel A; Schwarzmann G; Sandhoff K
Eur J Biochem; 1991 Sep; 200(2):591-7. PubMed ID: 1889421
[TBL] [Abstract][Full Text] [Related]
4. Specificity of galactosylceramidase activation by phosphatidylserine.
Hanada E; Suzuki K
Biochim Biophys Acta; 1980 Aug; 619(2):396-402. PubMed ID: 6773584
[TBL] [Abstract][Full Text] [Related]
5. Galactosylceramide- and lactosylceramide-loading studies in cultured fibroblasts from normal individuals and patients with globoid cell leukodystrophy (Krabbe's disease) and GM1-gangliosidosis.
Kobayashi T; Shinnoh N; Goto I; Kuroiwa Y; Okawauchi M; Sugihara G; Tanaka M
Biochim Biophys Acta; 1985 Jul; 835(3):456-64. PubMed ID: 3926002
[TBL] [Abstract][Full Text] [Related]
6. Globoid cell leukodystrophy (Krabbe's disease). Metabolic studies with cultured fibroblasts.
Tanaka H; Suzuki K
J Neurol Sci; 1978 Oct; 38(3):409-19. PubMed ID: 731265
[TBL] [Abstract][Full Text] [Related]
7. Only sphingolipid activator protein B (SAP-B or saposin B) stimulates the degradation of globotriaosylceramide by recombinant human lysosomal alpha-galactosidase in a detergent-free liposomal system.
Kase R; Bierfreund U; Klein A; Kolter T; Itoh K; Suzuki M; Hashimoto Y; Sandhoff K; Sakuraba H
FEBS Lett; 1996 Sep; 393(1):74-6. PubMed ID: 8804427
[TBL] [Abstract][Full Text] [Related]
8. Hydrolysis of galactosylceramide is catalyzed by two genetically distinct acid beta-galactosidases.
Kobayashi T; Shinnoh N; Goto I; Kuroiwa Y
J Biol Chem; 1985 Dec; 260(28):14982-7. PubMed ID: 3934152
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators.
Wilkening G; Linke T; Sandhoff K
J Biol Chem; 1998 Nov; 273(46):30271-8. PubMed ID: 9804787
[TBL] [Abstract][Full Text] [Related]
10. Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts.
Sadeghlar F; Remmel N; Breiden B; Klingenstein R; Schwarzmann G; Sandhoff K
Biochimie; 2003; 85(3-4):439-48. PubMed ID: 12770782
[TBL] [Abstract][Full Text] [Related]
11. Properties of a protein activator of glycosphingolipid hydrolysis isolated from the liver of a patient with GM1 gangliosidosis, type 1.
Inui K; Wenger DA
Biochem Biophys Res Commun; 1982 Mar; 105(2):745-51. PubMed ID: 6807306
[No Abstract] [Full Text] [Related]
12. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide.
Li SC; Kihara H; Serizawa S; Li YT; Fluharty AL; Mayes JS; Shapiro LJ
J Biol Chem; 1985 Feb; 260(3):1867-71. PubMed ID: 2981875
[TBL] [Abstract][Full Text] [Related]
13. Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1).
Inui K; Wenger DA
Arch Biochem Biophys; 1984 Sep; 233(2):556-64. PubMed ID: 6435528
[TBL] [Abstract][Full Text] [Related]
14. Morquio disease, type B: activation of GM1-beta-galactosidase by GM1-activator protein.
Paschke E; Kresse H
Biochem Biophys Res Commun; 1982 Nov; 109(2):568-75. PubMed ID: 6817758
[No Abstract] [Full Text] [Related]
15. A comparison of the properties and bile salt specificities of galactosylceramide and lactosyl ceramide beta-galactosidase activities in human leucocytes and fibroblasts.
Poulos A; Beckman K
Clin Chim Acta; 1980 Feb; 101(2-3):277-85. PubMed ID: 6766828
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice.
Sun Y; Zamzow M; Ran H; Zhang W; Quinn B; Barnes S; Witte DP; Setchell KD; Williams MT; Vorhees CV; Grabowski GA
Hum Mol Genet; 2013 Jun; 22(12):2435-50. PubMed ID: 23446636
[TBL] [Abstract][Full Text] [Related]
17. Human erythrocyte multicatalytic proteinase: activation and binding to sulfated galacto- and lactosylceramides.
Ohkubo I; Gasa S; Namikawa C; Makita A; Sasaki M
Biochem Biophys Res Commun; 1991 Feb; 174(3):1133-40. PubMed ID: 1825464
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of galactosylceramide in the twitcher mouse, an animal model of human globoid cell leukodystrophy.
Kobayashi T; Shinnoh N; Kuroiwa Y
Biochim Biophys Acta; 1986 Nov; 879(2):215-20. PubMed ID: 3094585
[TBL] [Abstract][Full Text] [Related]
19. Expression and specificity of human GM2 activator protein.
Wu YY; Lockyer JM; Sugiyama E; Pavlova NV; Li YT; Li SC
J Biol Chem; 1994 Jun; 269(23):16276-83. PubMed ID: 8206933
[TBL] [Abstract][Full Text] [Related]
20. The specificity of beta-galactosidase in the degradation of gangliosides.
Suzuki K; Tanaka H; Yamanaka T; Van Damme O
Adv Exp Med Biol; 1980; 125():307-18. PubMed ID: 6767344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
